RIGL
Rigel Pharmaceuticals Inc
Price:  
19.36 
USD
Volume:  
142,458.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RIGL Relative Valuation

16.0%
Upside

As of 2025-06-20, the Relative Valuation of Rigel Pharmaceuticals Inc (RIGL) is 22.46 USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.36 USD, the upside of Rigel Pharmaceuticals Inc based on Relative Valuation is 16.0%.

The range of the Relative Valuation is 16.48 - 37.16 USD.

Range Selected
Trailing P/E multiples 11.1x - 17.9x 12.3x
Forward P/E multiples 17.3x - 24.9x 20.3x
Fair Price 16.48 - 37.16 22.46
Upside -14.9% - 91.9% 16.0%
19.36 USD
Stock Price
22.46 USD
Fair Price

RIGL Relative Valuation - Historical P/E Data

Date P/E
2025-06-17 9.21
2025-06-16 9.82
2025-06-13 9.86
2025-06-12 10.24
2025-06-11 10.19
2025-06-10 10.36
2025-06-09 10.50
2025-06-06 10.33
2025-06-05 10.08
2025-06-04 9.87
2025-06-03 9.80
2025-06-02 9.69
2025-05-30 9.23
2025-05-29 9.39
2025-05-28 9.22
2025-05-27 9.43
2025-05-23 9.11
2025-05-22 9.48
2025-05-21 10.07
2025-05-20 9.67
2025-05-19 9.47
2025-05-16 9.53
2025-05-15 9.49
2025-05-14 8.79
2025-05-13 8.79
2025-05-12 8.95
2025-05-09 9.02
2025-05-08 9.08
2025-05-07 8.88
2025-05-06 8.78
2025-05-05 9.19
2025-05-02 9.31
2025-05-01 9.00
2025-04-30 9.40
2025-04-29 9.41
2025-04-28 9.33
2025-04-25 9.27
2025-04-24 9.16
2025-04-23 8.73
2025-04-22 8.53
2025-04-21 8.14
2025-04-17 8.10
2025-04-16 7.93
2025-04-15 8.19
2025-04-14 8.27
2025-04-11 8.02
2025-04-10 7.82
2025-04-09 8.30
2025-04-08 7.87
2025-04-07 8.19